OR10J6P

Across TCGA pan-cancer cohorts, OR10J6P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of OR10J6P’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where OR10J6P RNA is repressed in tumor relative to normal tissue. In most cancer types OR10J6P is over-expressed in tumor, although a few such as LIHC and KICH show the opposite, repressed pattern.

LIHC, KICH, and CHOL are the cancer types where OR10J6P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR10J6P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Female	All	−0.934	.001	5	view →
KICH	All	II,III,IV	−0.034	.009	2	view →
CHOL	Male	All	−1.405	.004	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

OR10J6P–LIHC

Open the LIHC breakdown →